Cost-Effectiveness of a Real-Time Continuous Glucose Monitoring System Versus Self-Monitoring of Blood Glucose in People with Type 2 Diabetes on Insulin Therapy in the UK

John J. Isitt,Stéphane Roze,Helen Sharland,Greg Cogswell,Hamza Alshannaq,Gregory J. Norman,Peter M. Lynch
DOI: https://doi.org/10.1007/s13300-022-01324-x
2022-10-20
Diabetes Therapy
Abstract:Real-time continuous glucose monitoring (rt-CGM) involves the measurement and display of glucose concentrations, potentially improving glucose control among insulin-treated patients with type 2 diabetes (T2D). The present analysis aimed to conduct a cost-effectiveness analysis of rt-CGM versus self-monitoring of blood glucose (SMBG) based on a USA retrospective cohort study in insulin-treated people with T2D adapted to the UK.
endocrinology & metabolism
What problem does this paper attempt to address?